Melanoma experts to share latest in prevention, treatment, research
10/24/14 Portland, Ore.
Event will include question-and-answer sessions with physicians, researchers and prevention experts along with cancer survivors who will share what they’ve learned
Melanoma Care Update and Patient Dialogue co-sponsored by the Knight Cancer Institute at Oregon Health & Science University’s Community Melanoma Registry and AIM at Melanoma
8 a.m. to noon, Nov. 15, 2014
OHSU Doernbecher Children’s Hospital, 11th floor, Vey Auditorium, 3181 S.W. Sam Jackson Park Road, Portland, Oregon 97239-3098
Keynote speaker Gerald Linette, M.D., Ph.D., associate professor of medicine and neurosurgery at Washington University in St. Louis, Missouri, will discuss the future of melanoma treatments that harness the immune system.
Sancy Leachman, M.D., Ph.D., director of the OHSU Knight Cancer Institute Melanoma Program, will share how she’s planning to reduce skin cancer rates and advance research through the newly established Community Melanoma Registry.
Other speakers will discuss surgical options and clinical trials.
Parking and refreshments will be provided. For more information, including the full event agenda, visit OHSU's Melanoma Community Registry website.
About the Knight Cancer Institute
The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of personalized cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down cells that enable cancer to grow without harming healthy cells. This breakthrough has made once-fatal forms of the disease manageable and ushered in a new generation of targeted cancer therapies. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It offers the latest treatments and technologies as well as hundreds of research studies and clinical trials.